NEWS FROM BRUCE

Bruce,

Thank you for this information. I will pass it on to our blog and website. I am so happy all is well. BTW, your brother is also doing great and in addition to being cured with a non detectable PSA after HIFU, he too has had no side effects or complications. Places like John Hopkins are academic centers that typically lag behind the day to day"pulse" of new and disruptive treatments. On the other hand, Dr Mark Schoenberg, chief of urologic oncology at John Hopkins is the Chief Medical Officer for USHIFU. Therefore, there is an obvious connection and a believe in our technology (HIFU) by the John Hopkins department of urology.

Tried and time,,, I am sure HIFU will prevail as the optimal treatment for localized prostate cancer
Regards,

George


George M. Suarez, M.D.



-----Original Message-----
From: Bruce Howard
To: gmsuarezmd@aol.com
Sent: Wed, Aug 4, 2010 1:00 pm
Subject: Fw: Fwd: Enlarged Prostate: Acupuncture for Chronic Prostatitis


My Acupuncturist asked me to send this to you, I'm sure in the hopes that you will recommend him to some of your client's with Prostatitis. He has helped me numerous times over the years with assorted ills. I don't know if you have any faith in Eastern medicine, but I thought I would forward it to you as a favor to him. When I read the suggested treatments for prostate cancer it blows my mind that an institute like Johns Hopkins, so highly regarded, does not even list HIFU as a suggested treatment. Maybe the article was too old. I appreciate what you must go through trying to get your miraculous treatment through the "old school" people in the Medical profession.

I got my psa score back and it was 0.07......thanks again. Continue to have patients contemplating the treatment call me and I will preach the gospel according to George.

Hope all is good with you.


Bruce Howard
Principal

BRUCE HOWARD & ASSOCIATES
Landscape Architects, Site Planners, & Golf Course Designers
4872 S.W. 72nd Avenue
Miami, Florida 33155
(305) 668-3196 Phone
(305) 668-2871 Fax
e-mail: bruce@brucehoward.net
----- Original Message -----
From: Santiago Sifre
To: Bruce Howard
Sent: Wednesday, August 04, 2010 10:26 AM
Subject: Fw: Fwd: Enlarged Prostate: Acupuncture for Chronic Prostatitis


Bruce, maybe you cn send this to your prostate guy and let him know on my behalve that it came from me. I would appreaciate it.



----- Forwarded Message ----
From: Dan Radcliffe
To: Santiago Sifre
Sent: Wed, November 18, 2009 11:44:56 AM
Subject: Fwd: Enlarged Prostate: Acupuncture for Chronic Prostatitis





Begin forwarded message:


From: Johns Hopkins Health Alerts

Date: November 17, 2009 10:02:02 AM EST

To: danradcliffe@mac.com

Subject: Enlarged Prostate: Alternative Treatment for Chronic Prostatitis

Reply-To: editor@johnshopkinshealthalerts.com


Johns Hopkins Health Alerts:
Enlarged Prostate and Prostatitis
Alternative Treatment for Chronic Prostatitis May Help
Should you try acupuncture to relieve the pain of chronic prostatitis? Results from a recent study provide the answer. Read on ...

(800) 829-0422www.johnshopkinshealthalerts.com | Johns Hopkins Health Bookstore | Email this to a friend
Alternative Treatment for Chronic Prostatitis May Help





Should you try acupuncture to relieve the pain of chronic prostatitis? Results from a recent study provide the answer.
Like other forms of chronic pain, chronic prostatitis is a complex condition with no simple solutions. Successful management depends on treating the original source of the pain as well as the neurological and psychosocial problems that often accompany it.
As a result, your doctor may prescribe several different types of medication. Some men also benefit from cognitive behavioral therapy, which can help improve coping strategies and psychological well-being.
But what if you've tried medications and they haven't helped? Should you give acupuncture a try?
Results from a small study in The American Journal of Medicine suggest that acupuncture may provide relief to men with chronic prostatitis. The study compared the potential benefits of acupuncture versus sham (inactive) treatments in 89 men who had symptoms of chronic prostatitis for three or more of the past six months and who had a score of 15 or higher on the National Institutes of Health Chronic Prostatitis Symptom Index.
The men were randomly assigned to receive two acupuncture treatments or two sham treatments a week for 10 weeks. The sham treatments were nearly identical to genuine acupuncture needle insertions except for the location and depth of placement.
True acupuncture was nearly twice as effective as the sham procedure in relieving chronic prostatitis symptoms. Moreover, patients treated with acupuncture were more than twice as likely as the men given the inactive treatment to experience long-term prostatitis relief. Few of the men experienced complete resolution of their symptoms.
This study supports findings from other trials showing a benefit from acupuncture for chronic prostatitis. More study is needed before the treatment can definitively be recommended, but if nothing else has worked for you, a trial of acupuncture might be worth considering.



--------------------------------------------------------------------------------






If you found this health alert interesting and are ready to take the next step, we recommend our authoritative Johns Hopkins Prostate Bulletin. The Johns Hopkins Prostate Bulletin is an indispensable quarterly journal for men with prostate cancer and the other prostate health concerns, including benign prostatic hyperplasia (BPH) and prostatitis. It also deals with side effects and related conditions, such as lower urinary tract symptoms (LUTS), overactive bladder, and erectile dysfunction.


Written by Dr. Jacek L. Mostwin and his esteemed colleagues at the world-renowned James Buchanan Brady Urological Institute, The Johns Hopkins Prostate Bulletin goes beyond the basics to report on the latest therapeutic treatments, advanced news of clinical trials, in-depth reports, new medications, plus detailed answers to subscribers' concerns about all aspects of your prostate health.
Order today at the special web-only discount and you'll receive five FREE Special Reports as INSTANT PDF DOWNLOADS.
For more information, or to order, go to: The Johns Hopkins Prostate Bulletin










Johns Hopkins Publications









Choosing The Right Treatment For Your Prostate Cancer
Choosing the Right Treatment for Your Prostate Cancer is a must-read primer for any man recently diagnosed with prostate cancer who is looking for answers to pressing questions about treatment options. Our specialists explain in-depth:
1.Expectant Management
2.Brachytherapy
3.Radical Prostatectomy
4.External Beam Radiation Therapy
Access the expertise of the specialists at America's #1 Urology Center in this Special Report designed with YOU in mind, to give you the most timely, accurate information on prostate cancer care and treatment.


Look In the Book: Choosing the Right Treatment for Your Prostate Cancer

Read more or order Choosing the Right Treatment for Your Prostate Cancer







Advanced Prostate Cancer Treatments -- Know Your Options When Your Cancer Comes Back
This 113-page guide features discussions with leading experts at Johns Hopkins on specific options for treating advanced prostate cancer to help you sift through all your options to decide the treatment path(s) that are right for YOU. You will learn about current therapies as well as new approaches being developed here at Johns Hopkins and other important medical centers. These treatments include gene therapy to stop the advance of the disease, monoclonal antibodies that zap cancer cells throughout the body, a variety of chemotherapy agents such as Taxotere and angiogenesis inhibitors, drugs that choke off the blood supply to tumors.


Read more or order Advanced Prostate Cancer Treatments





Restoring Sexual Intimacy After Prostate Cancer Treatment
Written by Drs. Jacek Mostwin and H. Ballentine Carter from Hopkins' James Buchanan Brady Urological Institute, Restoring Sexual Intimacy After Prostate Cancer Treatmentpresents the latest thinking on erection rehabilitation after radical prostatectomy. It explore the full range of your erectile dysfunction treatment options -- effective oral medications, injection therapy, penile implants, and more. The report includes answers to dozens of real questions from patients on sexuality and prostate cancer.


Read more or order Restoring Sexual Intimacy After Prostate Cancer Treatment








--------------------------------------------------------------------------------

You are receiving this email as part of your free subscription to Johns Hopkins Health Alerts. Should you wish to unsubscribe, please follow the instructions below. Help us be sure this email Health Alert isn't filtered as spam. Adding our return address johnshopkins to your address book may 'whitelist' us with your filter, helping future Health Alerts get to your inbox.

Did a friend send this to you? Sign up to get your own alert here
Send this email alert to a friend
Unsubscribe from this mailing list
Subscribe to additional health alerts
Update your profile
Need to contact us? Click here: http://www.johnshopkinshealthalerts.com/contact_us/?ET=johnshopkins_blog:e33343:122752a:&st=email

Johns Hopkins Health Alerts
500 Fifth Avenue
19th Floor
New York, NY 10110
Attn: Web Team
We value your privacy and will not rent your email address to anyone. Click here to view our privacy policy.
This information is not intended to substitute for the advice of a physician. Click here for additional information.

Copyright © 2009 MediZine LLC. 500 Fifth Avenue, 19th Floor, New York, NY 10110. All rights reserved.




Johns Hopkins Featured Title:





2009 Prostate Disorders White Paper
This all-in-one comprehensive guide explains everything you need to know about your prostate -- what it is, what it does, and what problems can develop, such as prostatitis, benign prostatic hyperplasia (BPH or enlarged prostate), and prostate cancer. You'll learn key facts about prostate health, discover prostate treatments you never knew existed, and understand what your options are if you're ever diagnosed with prostate cancer. 96 pages.
Read more or order the INSTANT PDF DOWNLOAD EDITION
Read more or order the PRINT EDITION

--------------------------------------------------------------------------------




Come see what's NEWin the
Bookstore
Here you'll find Newsletters, Bulletins, White Papers in both print and instant PDF download formats, plus our latest FREE Special Reports. Johns Hopkins Bookstore




Johns Hopkins has been ranked #1 of America's Best Hospitals by
U.S. News and World Reportfor the 19th consecutive year, ranking #1 in Ear, Nose and Throat, Rheumatology and Urology. For more information, please visit: America's Best Hospital.

Please visit here for more information about Johns Hopkins Patient Services










ReplyReply AllMove...AMERICAN ALBILL McCOLLUMCONTINENTAL ALGLOBALINSURANCEHIFU FOLDERIMPORTANT SAVEDJOSHsavesavedSUAREZGo to Previous message | Go to Next message | Back to Messages Select Message EncodingASCII (ASCII)Greek (ISO-8859-7)Greek (Windows-1253)Latin-10 (ISO-8859-16)Latin-3 (ISO-8859-3)Latin-6 (ISO-8859-10)Latin-7 (ISO-8859-13)Latin-8 (ISO-8859-14)Latin-9 (ISO-8859-15)W. European (850)W. European (CP858)W. European (HPROMAN8)W. European (MACROMAN8)W. European (Windows-1252)Armenia (ARMSCII-8)Baltic Rim (ISO-8859-4)Baltic Rim (WINDOWS-1257)Cyrillic (866)Cyrillic (ISO-8859-5)Cyrillic (KOI8-R)Cyrillic (KOI8-RU)Cyrillic (KOI8-T)Cyrillic (KOI8-U)Cyrillic (WINDOWS-1251)Latin-2 (852)Latin-2 (ISO-8859-2)Latin-2 (WINDOWS-1250)Turkish (ISO-8859-9)Turkish (WINDOWS-1254)Arabic (ISO-8859-6,ASMO-708)Arabic (WINDOWS-1256)Hebrew (856)Hebrew (862)Hebrew (WINDOWS-1255)Chinese Simplified (GB-2312-80)Chinese Simplified (GB18030)Chinese Simplified (HZ-GB-2312)Chinese Simplified (ISO-2022-CN)Chinese Simplified (WINDOWS-936)Chinese Trad.-Hong Kong (BIG5-HKSCS)Chinese Traditional (BIG5)Chinese Traditional (EUC-TW)Japanese (SHIFT_JIS)Japanese (EUC-JP)Japanese (ISO-2022-JP)Korean (ISO-2022-KR)Korean (EUC-KR)Thai (TIS-620-2533)Thai (WINDOWS-874)Vietnamese (TCVN-5712)Vietnamese (VISCII)Vietnamese (WINDOWS-1258)Unicode (UTF-7)Unicode (UTF-8)Unicode (UTF-16)Unicode (UTF-32)| Full Headers Reply Reply All Forward Forward
.

Mail Search

WelcomeInboxNewFoldersMail Options


Copyright 2010 © Yahoo! Inc. Privacy Policy | About Our Ads | Terms of Service | Send Feedback | Help

CLICK IN TO MY WEBSITE!

There is new information on Dr. George M. Suarez' website. Make sure that you visit his website:
www.hifumedicalexpert.com - Comments are welcome

MR guided HIFU

Rapid motion correction in MR-guided high-intensity focused ultrasound heating using real-time ultrasound echo information
Philippe Lourenço de Oliveira, Baudouin Denis de Senneville *, Iulius Dragonu, Chrit T. W. Moonen
Laboratory for Molecular and Functional Imaging: From Physiology to Therapy, UMR 5231 CNRS/Université Bordeaux 2, Bordeaux, France

email: Baudouin Denis de Senneville (baudouin@imf.u-bordeaux2.fr)

*Correspondence to Baudouin Denis de Senneville, UMR 5231, Imagerie Moléculaire et Fonctionnelle, Université Victor Segalen Bordeaux 2, 146, rue Léo Saignat, case 117, 33076 Bordeaux, France.

These two authors contributed equally.
Funded by:
Ligue Nationale Contre le Cancer, Conseil Régional d'Aquitaine: Diagnostic Molecular Imaging EC-FP6-project LSHB-CT-2005-512146
Agence National de la Recherche; project MRgHIFU-ALKT
Philips Healthcare

Bojangles on HIFU and ED

people treated with Hifu
by bojangles on Sat Jul 31, 2010 10:09 PM

Quote | Reply Looking for anyone in the late 50's who have had HIFI treatments. Would love to talk to them and see how they're doing. How's your sex life.
You can find me in Cancer Compass

MORTALITY RESULTS FROM THE GOTENBORG RANDOMISED POPULATION-BASED PROSTATE-CANCER SCREENING TRIAL

The Lancet Oncology, Early Online Publication, 1 July 2010
Mortality results from the Göteborg randomised population-based prostate-cancer screening trial
Original TextProf Jonas Hugosson MD a , Sigrid Carlsson MD a, Gunnar Aus MD a, Svante Bergdahl MD a, Ali Khatami MD a, Pär Lodding MD a, Carl-Gustaf Pihl MD c, Johan Stranne MD a, Erik Holmberg PhD b, Hans Lilja MD d e
Summary
Background
Prostate cancer is one of the leading causes of death from malignant disease among men in the developed world. One strategy to decrease the risk of death from this disease is screening with prostate-specific antigen (PSA); however, the extent of benefit and harm with such screening is under continuous debate.
Methods
In December, 1994, 20 000 men born between 1930 and 1944, randomly sampled from the population register, were randomised by computer in a 1:1 ratio to either a screening group invited for PSA testing every 2 years (n=10 000) or to a control group not invited (n=10 000). Men in the screening group were invited up to the upper age limit (median 69, range 67—71 years) and only men with raised PSA concentrations were offered additional tests such as digital rectal examination and prostate biopsies. The primary endpoint was prostate-cancer specific mortality, analysed according to the intention-to-screen principle. The study is ongoing, with men who have not reached the upper age limit invited for PSA testing. This is the first planned report on cumulative prostate-cancer incidence and mortality calculated up to Dec 31, 2008. This study is registered as an International Standard Randomised Controlled TrialISRCTN54449243.
Findings
In each group, 48 men were excluded from the analysis because of death or emigration before the randomisation date, or prevalent prostate cancer. In men randomised to screening, 7578 (76%) of 9952 attended at least once. During a median follow-up of 14 years, 1138 men in the screening group and 718 in the control group were diagnosed with prostate cancer, resulting in a cumulative prostate-cancer incidence of 12·7% in the screening group and 8·2% in the control group (hazard ratio 1·64; 95% CI 1·50—1·80; p<0·0001). The absolute cumulative risk reduction of death from prostate cancer at 14 years was 0·40% (95% CI 0·17—0·64), from 0·90% in the control group to 0·50% in the screening group. The rate ratio for death from prostate cancer was 0·56 (95% CI 0·39—0·82; p=0·002) in the screening compared with the control group. The rate ratio of death from prostate cancer for attendees compared with the control group was 0·44 (95% CI 0·28—0·68; p=0·0002). Overall, 293 (95% CI 177—799) men needed to be invited for screening and 12 to be diagnosed to prevent one prostate cancer death.
Interpretation
This study shows that prostate cancer mortality was reduced almost by half over 14 years. However, the risk of over-diagnosis is substantial and the number needed to treat is at least as high as in breast-cancer screening programmes. The benefit of prostate-cancer screening compares favourably to other cancer screening programs.
Funding
The Swedish Cancer Society, the Swedish Research Council, and the National Cancer Institute

THE ADVANTAGES OF HIFU

Great article in the WSJ on the University of Gothenburg's findings on the value of PSA to be more sensitive that in screening for other types of common cancers, such as breast and colon cancer. The facts are: 1) PSA is the most precise and sensitive of all tumor markers. 2) Prostate cancer is the most common cancer in men. 3) Prostate cancer is the second most common cancer in men. 4) If detected early, it's curable. The conclusion of the Gothenburg research: PSA screening and treatment can reduce the risk of death from prostate cancer by as much as 50%.
The real challenge for men is when it comes to choosing a treatment. There lies the real issue, in that among physician worldwide, there is no general consensus as to the optimal treatment. Instead, treatment recommendations are a bias of the specialty and the training of the treating physician: surgeons will recommend surgery, and radiation oncologist radiation. As the saying goes: "to hammer everything looks like a nail." Likewise, is the bias when it comes to treating prostate cancer. The latest craze is the Robotic prostatectomy! However, most recent evidence shows that Robotic prostatectomy has a higher risk of recurrence and no better clinical outcomes in the incidence of impotence and urinary incontinence. After all, it's still the same human hands directing the Robotic instruments.
Other unique characteristic about prostate cancer is that the standard treatments available come with a high risks of complications. Particularly in quality of life matters such as greater than 50% incidence of impotence and 10-20 % risk of urinary incontinence associated with surgical removal of the prostate. There are similar risks with radiation. Plus a high risk of developing a secondary cancer from the exposure to the radiation. These issues are so concerning to men, that they often elect on "watchful waiting" or "active surveillance" at the risk of progression of cancer and metastasis... another unique characteristic of prostate cancer. I certainly know of no malignancy where a patient would consider opting for no treatment at the risk of death.
For the past 7 years I have offered High Intensity Focused Ultrasound or HIFU to patients with localized prostate cancer. The technology has been approved in Europe and other countries since 1998, and currently is approved worldwide, except in the U.S. However, American urologist have embraced the procedure and travel with their patients to treat them in countries where it is approved. Another unique characteristic of prostate cancer: American urologist and their patients are willing to travel outside the U.S. in order to perform and receive this very advanced futuristic treatment. But this is not really unique, as Americans are familiar with seeking health care outside the U.S. while procedures and medications are pending FDA approval.
The principle advantage to HIFU is that there are less risk of impotence and incontinence: the two most dreaded potential complication feared by men. Clinical efficacy of HIFU in recent years has proven post treatment PSA (PSA Nadir) of the same range as surgical removal or radiation therapy. To the skeptics, the initial impression is that the whole thing is too good to be true. But it is that good, in efficacy of treatment, and less risk of complications. Otherwise, the FDA would not have allowed the clinical trials to progress from Phase I and II, to current phase III. Another interesting bit of information: None of the "standard" treatments available for treating prostate cancer was ever FDA approved, nor did any of them undergo any type of clinical trial. Instead they were "grand- fathered" as treatments that were used prior to more rigorous FDA regulation came into place.
The Gothenburg study will undoubtedly influence the application of PSA screening by both physician's use and patient's request. Unfortunate, this will lead to the potential risk of overtreatment and increase number of patients at risk of compromised quality of life. The American Cancer Society reports approximately 250,000 new cases of prostate cancer per year. Increase screening, as well longer living population, will lead to more patients diagnosed with prostate cancer. Potentially doubling the number of newly diagnosed patients per year. As well as creating a huge economic burden, if not a crisis in the cost of healthcare. The cost of treatments does vary, with radiation being the most costly. The cost of a HIFU treatment is significantly less than all standard treatments. In Addition, as an outpatient procedure, it allows the patient to return to work and other routine activities the day after treatment is a plus for patient convenience as well as lost of revenue and productivity.
How likely is HIFU to get FDA approval? Having personally performed over 2,000 cases, and trained hundreds of urologist from around the world, I am confident that HIFU will be approved. It just a matter of the time it takes to complete the trials. What impact will HIFU have as a treatment option for prostate cancer? Several Biomedical Wall Street analysts and industry newsletters predict a 91% compounded yearly growth over the next five years, with HIFU becoming the most common treatment for prostate cancer by 2015. I never imagined a four letter word would impact healthcare so positively and so powerfully. But it has happened before. I remember the huge incisions we made to remove tiny kidney stone, the ensuing pain and days of recovery. Sometimes resecting ribs and injuring adjacent tissue and whole organs. Then there came another four letter word: ESWL, (extracorporael shock wave lithotripsy) and no more opened surgery for kidney stones. ESWL was approved by the FDA in 1884. Interestingly, the science and technology of ESWL is the same as for HIFU. It's called piezoelectric energy. How big is HIFU as an available treatment for the most common cancer in men, and the second most common cause of death related to cancer versus the impact of ESWL? Kidney stone affects a small number of Americans, and patients typically don't die from kidney stones.
George M. Suarez, M.D. F.A.C.S.
Board Certified Urologist
305-595-0199
9195 Sunset Dr. Suite 110
Miami, Florida
www.hifumedicalexpert.com

JUMP LINE - DADE COUNTY ASSOCIATION OF FIREFIGHTERS APRIL- JUNE 2010 Vol.29.No.2

ALTERNATIVE TREATMENT
By
F F Jim Bruce


PROSTATE CANCER is the most common cancer in men and the second leading cause of cancer related deaths. If detected early, it can be successfully treated using one or more of the accepted treatment options. Options are: radiation, proton beam, radical, robotic, and cryostherapy. All of these treatment have had success in destroying the cancer. Unfortunately, all of these treatments have high incidences of collateral damage. Incontinence, impotence, and recurrence are fairly common and are of great concern for patients after the procedure. Several of our brothers have had to be treated for prostate cancer and they have used more than one of the above treatments. The side effects can be as devastating to the patient as the cancer. Once the cancer is resolved, which of these treatments will allow us to return to a normal life as quickly as possible? For this reason, I write this article.

I have witnessed the devastating effects the robotic treatment had on one of our brothers and would like to tell all of you, so you can pass it on to a family member or friend. There is a treatment that is available but is not widely known about. That treatment is High Intensity Focused Ultrasound (HIFU). Although HIFU has not yet been approved by the FDA, it has been approved and is currently being used in every other developed country in the world. In fact, HIFU is the ONLY prostate cancer treatment that has ever had to undergo FDA Clinical Trials. All other available treatment options in the U.S. have been “grandfathered” in. I guess you can say that HIFU is a victim of timing!

I want you to know about HIFU because it has provided several of our brothers with remarkable results. These brothers are returning to a full and fulfilling life very quickly with minimal or no issues. I have not mentioned any names because, in this format I believe it would be inappropriate.

All of the guys, that had HIFU, are extremely happy and are willing to speak to anyone that might have questions. The brother that had the robotic treatment asked me to get this message our because of my relationship with the Doctor that started HIFU. He wishes someone had told him about this procedure so he would have had information about all the different options available, I am not saying there will never be a negative side effect with this procedure. The guys that have had it done tell me they have experienced no negative side effects. As a person that plays the odds, this would be the procedure for me and this is the procedure I would direct my family towards.

U.S. citizens have to go to either Nassau, Mexico, or Canada to have this procedure done. Do not let that scare you. These facilities are top of the line and a Doctor from the U.S. will be there to do the procedure. In years past, the patient had to absorb the entire cost for this procedure. Currently, many insurance companies, including Dade County Fire Fighters Insurance Trust, are paying some or all of the cost for this procedure.

Dr. George M. Suarez is the founder of USHIFU and has treated over two thousand men, including several of our own. He will be conducting seminars May 12, August 11, and October 19, 2010 at the Biltmore Hotel in Coral Gables, where he will be discussing all treatment options. He will be available to speak to you individually. He is a personal friend of mine, who is helping our brothers, and I wish to let as many people know about this seemingly wonderful procedure.

If you have any questions, call me: Jim